Exhibit 99.1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the common shares of Medicenna Therapeutics Corp. and further agree that this agreement be included as an exhibit to such filings. Each party to this agreement agrees that this joint filing agreement may be signed in counterparts.
In evidence whereof, the undersigned have caused this agreement to be executed on their behalf this February 10, 2022.
| /s/ Fahar Merchant | ||
| Name: | Fahar Merchant | |
| Title: | Chairman, President and Chief Executive Officer, Medicenna Therapeutics Corp. | |
| /s/ Rosemina Merchant | ||
| Name: | Rosemina Merchant | |
| Title: | Chief Development Officer, Medicenna Therapeutics Corp. | |
| ARIES BIOLOGICS INC. | ||
| By: | /s/ Fahar Merchant | |
| Name: | Fahar Merchant | |
| Title: | Chairman, President and CEO | |
